Rising Cancer Incidence Fuels Demand for Smart Nanomedicine Solutions in Oncology CareThe Smart Cancer Nanomedicine Market ...
The global pharmaceutical drug delivery market is witnessing steady growth, driven by advancements in formulation ...
Use Alt + Down Arrow to expand. This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For ...
State Key Laboratory of Natural Medicines, Department of Pharmaceutics, School of Pharmacy, China Pharmaceutical University, Nanjing 211198, P. R. China NMPA Key Laboratory for Research and Evaluation ...
Patient-centric drug development improves adherence and outcomes by focusing on patient needs and preferences, with regulatory support from bodies like the FDA. Special populations, including ...
Duke researchers have developed a new AI-powered approach to nanoparticle drug delivery design, which performed well in lab tests with cancer drugs Drugs that fight diseases work best when they reach ...
Clinical trials can present many challenges for patients–particularly injections. Oliver Eden, senior business unit director at Jabil, and Travis Webb, chief scientific officer at PII, discuss nuance, ...
In a merger between two subcutaneous drug delivery companies, Halozyme Therapeutics is paying $750 million in cash to acquire Elektrofi. Aside from the $750 million upfront payment, the deal also ...
Oct 1 (Reuters) - Halozyme Therapeutics (HALO.O), opens new tab said on Wednesday it has agreed to acquire privately held Elektrofi in a deal worth up to $900 million to expand its drug delivery ...
INAMAT─Institute for Advanced Materials and Mathematics, Dept. Science, Public University of Navarra, Campus Arrosadía, 31006 Pamplona, Spain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback